Internal Medicine, Clinical Cardiatric Electrophysiology · Mesa, AZ
NPI
1609893502
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6750 E Baywood Ave # 301
Mesa, AZ, 85206
Phone (480) 835-6100
Groups this clinician bills Medicare through
Medicare paid, 2024
$940K
13,954 services
Medicare patients, 2024
2,088
Average age 78
Drug cost, 2024
$2.3M
10,795 prescriptions
Company payments, 2025
$882
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arun K Kolli was code 93296 (external electrocardiographic monitoring), 2,338 times for 805 patients. In total Arun K Kolli billed 13,954 services in 87 codes, and Medicare paid $940K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93296 External Electrocardiographic Monitoring | Office | 2,338 | 805 | $15.95 | $37K |
| 93294 External Electrocardiographic Monitoring | Office | 1,814 | 618 | $21.99 | $40K |
| 99214 Office E&M - Established | Office | 1,630 | 1,114 | $86.57 | $141K |
| 93000 Electrocardiogram | Office | 1,203 | 928 | $10.06 | $12K |
| 93298 External Electrocardiographic Monitoring | Office | 932 | 128 | $74.86 | $70K |
| 93280 External Electrocardiographic Monitoring | Office | 740 | 546 | $59.20 | $44K |
| 93295 External Electrocardiographic Monitoring | Office | 525 | 188 | $27.06 | $14K |
| 93306 Echocardiography (TTE/TEE) | Office | 470 | 460 | $126.15 | $59K |
| 93793 Care Management/Coordination | Office | 455 | 68 | $7.33 | $3,335 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 444 | 111 | $5.60 | $2,485 |
| 85610 Clinical Chemistry | Office | 371 | 61 | $4.20 | $1,558 |
| 99215 Office E&M - Established | Office | 316 | 256 | $131.47 | $42K |
| 93015 Electrocardiogram | Office | 149 | 149 | $49.69 | $7,404 |
| 99233 Hospital E&M - Subsequent | Facility | 137 | 48 | $90.00 | $12K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 134 | 67 | $410.43 | $55K |
By year: 2022 $945K for 15,128 services; 2023 $1.0M for 15,025 services; 2024 $940K for 13,954 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 371 | 61 | $4.20 | $1,558 |
Medicare prescription drug claims, 2024
In 2024, the drug Arun K Kolli prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,265 prescriptions and refills. In total Arun K Kolli wrote 10,795 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,265 | 2,592 | 334 | $1.5M |
| Metoprolol Succinate Generic | 735 | 2,009 | 286 | $9,806 |
| Metoprolol Tartrate Generic | 615 | 1,672 | 221 | $4,039 |
| Furosemide Generic | 549 | 1,444 | 199 | $2,953 |
| Sotalol Sotalol Hcl | 487 | 1,317 | 173 | $12K |
| Carvedilol Generic | 469 | 1,296 | 165 | $4,112 |
| Amlodipine Besylate Generic | 368 | 984 | 137 | $2,300 |
| Amiodarone Hcl Generic | 342 | 854 | 138 | $8,001 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 334 | 934 | 113 | $12K |
| Digoxin Generic | 313 | 816 | 88 | $7,256 |
| Losartan Potassium Generic | 313 | 889 | 113 | $3,180 |
| Lisinopril Generic | 304 | 885 | 113 | $1,983 |
| Atorvastatin Calcium Generic | 299 | 879 | 104 | $2,959 |
| Cephalexin Generic | 261 | 261 | 249 | $1,466 |
| Flecainide Acetate Generic | 255 | 651 | 81 | $12K |
Brand drugs: 2,165 claims; generic drugs: 8,630 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arun K Kolli $882 ($882 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $481.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.